KYOWA KIRIN LIMITED
Company Information
- Company Number
- 03504711
- Registered Address
- 1st Floor Sackville House, 143-149 Fenchurch Street, London, England, EC3M 6BL
- Status
- Active
- Employee Count
- 66
- Turnover
- £75,415,000
- EBITDA
- £3,210,000
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 30 January 1998
- Nature of Business
- 82990 - Other business support service activities not elsewhere classified
- Industries
- Life Sciences And Medical Technology
- Region
- London
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 28 Jul 2025 | 26 | 73% | 24% | 3% | 53% |
| 01 Jul 2024 - 31 Dec 2024 | 30 Jan 2025 | 28 | 73% | 23% | 4% | 38% |
| 01 Jan 2024 - 30 Jun 2024 | 24 Jul 2024 | 29 | 65% | 29% | 6% | 39% |
| 01 Jul 2023 - 31 Dec 2023 | 30 Jan 2024 | 34 | 62% | 29% | 9% | 41% |
| 01 Jan 2022 - 30 Jun 2022 | 26 Aug 2022 | 39 | 61% | 23% | 16% | 42% |
| 01 Jul 2021 - 31 Dec 2021 | 14 Feb 2022 | 35 | 73% | 13% | 14% | 31% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 36 | 74% | 14% | 12% | 28% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 38 | 51% | 38% | 11% | 55% |
| 01 Jul 2018 - 31 Dec 2018 | 23 Jan 2019 | 161 | 69% | 21% | 10% | 65% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Unless otherwise agreed in writing, Kyowa Kirin Limited will pay for third party goods or services, within 30 days of receipt of a correct, undisputed and properly due VAT invoice, such invoice to be provided by the supplier within the time contractually agreed with Kyowa Kirin Limited. Invoices must generally state: the contact details of the Kyowa Kirin Limited point of contact; the relevant purchase order number; the period to which the invoice relates; the Supplier’s bank account for payment; all charges and applicable taxes, and a description of the services/products. If Kyowa Kirin Limited has a bona fide dispute relating to all or some of the supplier’s invoices, Kyowa Kirin Limited may withhold payment of the amount, subject to resolution of the dispute.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
45
Dispute Resolution Process
Payment disputes are settled in the first instance by the purchase ledger team. In the event that a dispute cannot be resolved by our Accounts Payable team, it would escalate in the first instance to the relevant Head of Department to seek a resolution.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
KYOWA KIRIN LIMITED is a global pharmaceutical company that focuses on developing innovative and life-changing therapies for patients. The company was founded in Japan in 1949 and has since expanded its operations to Europe, North America, and Asia.
Sustainability is a key focus for KYOWA KIRIN LIMITED, and the company has implemented various initiatives to reduce its environmental impact. This includes using renewable energy sources, reducing waste and emissions, and promoting sustainable practices throughout its supply chain.
The company's main products and services include pharmaceuticals, biologics, and medical devices. These products are used to treat a wide range of diseases and conditions, including cancer, kidney disease, and immune disorders. KYOWA KIRIN LIMITED also offers support programs for patients to help them access and afford their medications.
The key people at KYOWA KIRIN LIMITED include President and CEO Masashi Miyamoto, who has been with the company since 1980 and has extensive experience in the pharmaceutical industry. The company also has a diverse team of scientists, researchers, and healthcare professionals who are dedicated to developing new and improved treatments for patients.
For more information about KYOWA KIRIN LIMITED and its products and services, you can visit their website at www.kyowa-kirin.com. The company's registered office address is 3 Galena Road, London, W6 0LT, United Kingdom.
